Delcath Systems Inc (DCTH)

Jan 13, 2025, 8:00 AM EST - 4 days ago

Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results

Jan 3, 2025, 4:01 PM EST - 14 days ago

Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Dec 30, 2024, 8:00 AM EST - 18 days ago

Delcath Systems Announces Additional $16.3 Million in Funding From Series E and E1 Warrant Exercises

Dec 2, 2024, 8:30 AM EST - 6 weeks ago

Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Colorectal Cancer

Nov 20, 2024, 7:50 AM EST - 2 months ago

Delcath Begins Platform Expansion With Two Phase 2 Trials

Nov 18, 2024, 7:09 AM EST - 2 months ago

Delcath Systems: Q3 Earnings Reveal HEPZATO KIT And CHEMOSAT Growth

Nov 8, 2024, 12:30 PM EST - 2 months ago

Delcath Systems Inc (DCTH) Q3 2024 Earnings Call Transcript

Nov 8, 2024, 8:00 AM EST - 2 months ago

Delcath Systems Reports Third Quarter 2024 Results and Business Highlights

Nov 1, 2024, 4:01 PM EDT - 2 months ago

Delcath Systems to Participate in Upcoming Investor Conferences

Oct 25, 2024, 8:30 AM EDT - 3 months ago

Delcath Systems to Host Third Quarter 2024 Earnings Call

Oct 17, 2024, 8:30 AM EDT - 3 months ago

Delcath Systems Announces Preliminary Third Quarter 2024 Revenue Results

Sep 20, 2024, 4:01 PM EDT - 4 months ago

Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sep 16, 2024, 8:30 AM EDT - 4 months ago

Delcath Systems Announces New Data Presented at ESMO 2024 Demonstrating Efficacy of HEPZATO KIT™ in Metastatic Uveal Melanoma Subgroups

Aug 28, 2024, 4:01 PM EDT - 5 months ago

Delcath Systems, Inc. Announces Positive Results from Independent Study on Liver-Directed Therapy for Uveal Melanoma Patients

Aug 28, 2024, 4:01 PM EDT - 5 months ago

Delcath Systems to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 27, 2024, 8:30 AM EDT - 5 months ago

Delcath Systems, Inc. Announces Positive Outcomes from Independent Study on Hepatic Perfusion for Uveal Melanoma Patients

Aug 26, 2024, 4:01 PM EDT - 5 months ago

Delcath Systems, Inc. Announces Promising Results from Independent Study on Repeated Hepatic Chemosaturation for Liver Tumors

Aug 23, 2024, 3:30 PM EDT - 5 months ago

Undercovered Dozen: Delcath Systems, Bavarian Nordic, Tempus AI, Journey Energy +

TEM

Aug 20, 2024, 8:30 AM EDT - 5 months ago

Delcath Systems Announces Poster Presentation at the 2024 ESMO Congress

Aug 18, 2024, 10:03 PM EDT - 5 months ago

Delcath Is On Schedule For A Monster 2025: A Platform Valuation Awaits

Aug 6, 2024, 1:54 AM EDT - 5 months ago

Delcath Systems Inc (DCTH) Q2 2024 Earnings Call Transcript

Aug 5, 2024, 4:01 PM EDT - 5 months ago

Delcath Systems Reports Second Quarter 2024 Results and Business Highlights

Aug 5, 2024, 8:30 AM EDT - 5 months ago

Delcath Systems Announces CMS Approval for NTAP for HEPZATO KIT™

Jul 22, 2024, 4:01 PM EDT - 6 months ago

Delcath Systems to Host Second Quarter 2024 Earnings Call

May 28, 2024, 9:30 AM EDT - 8 months ago

Delcath Systems Announces Appointment of Bridget Martell, MA, MD to Delcath's Board of Directors

May 14, 2024, 2:16 PM EDT - 8 months ago

Delcath Systems Inc (DCTH) Q1 2024 Earnings Call Transcript

May 14, 2024, 7:30 AM EDT - 8 months ago

Delcath Systems Reports First Quarter 2024 Results and Business Highlights

May 7, 2024, 8:30 AM EDT - 9 months ago

Delcath Systems to Host First Quarter 2024 Earnings Call

May 6, 2024, 9:00 AM EDT - 9 months ago

Publication of Results from Pivotal FOCUS Study in Metastatic Uveal Melanoma Patients treated with HEPZATO KIT

May 3, 2024, 5:15 PM EDT - 9 months ago

Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mar 26, 2024, 12:49 PM EDT - 10 months ago

Delcath Systems Inc (DCTH) Q4 2023 Earnings Call Transcript

Mar 26, 2024, 7:30 AM EDT - 10 months ago

Delcath Systems Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update

Mar 20, 2024, 8:15 AM EDT - 10 months ago

Delcath Systems Closes $7 Million Private Placement

Mar 19, 2024, 9:00 AM EDT - 10 months ago

Delcath Systems to Host Fourth Quarter and Full Year 2023 Results and Business Update Call

Mar 18, 2024, 5:20 PM EDT - 10 months ago

Delcath Systems Appoints Martha S. Rook as Chief Operating Officer

Mar 15, 2024, 8:20 AM EDT - 11 months ago

Delcath Systems Announces $7 Million Private Placement

Feb 22, 2024, 5:00 PM EST - 11 months ago

Delcath Systems Announces Healthcare Setting Locator for HEPZATO™ KIT (melphalan/Hepatic Delivery System)

Jan 31, 2024, 8:00 AM EST - 1 year ago

Delcath Systems Receives Permanent J-Code (J9248) for HEPZATO™ (melphalan/Hepatic Delivery System) Effective April 1, 2024

Jan 23, 2024, 8:00 AM EST - 1 year ago

Delcath Systems to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference

Jan 16, 2024, 8:00 AM EST - 1 year ago

Delcath Systems Announces U.S. Launch and First Commercial Treatment Utilizing HEPZATO KIT™

Dec 7, 2023, 9:00 AM EST - 1 year ago

Delcath Systems Announces Publication by Independent Investigators of a Retrospective Analysis of Quality of Life in the Journal Melanoma Research

Nov 17, 2023, 6:40 PM EST - 1 year ago

Adoption Of Delcath's Hepzato Kit Will Snowball Quicker Than The Market Expects

Nov 15, 2023, 5:00 PM EST - 1 year ago

Delcath Systems Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Nov 13, 2023, 10:07 PM EST - 1 year ago

Delcath Systems Inc. (DCTH) Q3 2023 Earnings Call Transcript

Nov 13, 2023, 4:05 PM EST - 1 year ago

Delcath Systems Reports Third Quarter 2023 Results and Provides Business Update

Nov 6, 2023, 4:30 PM EST - 1 year ago

Delcath Systems to Host Third Quarter 2023 Results Call

Oct 16, 2023, 8:30 AM EDT - 1 year ago

Delcath Systems Announces a Comparative Study of Chemosat and SIRT Published in the Journal Cancers

Oct 10, 2023, 8:30 AM EDT - 1 year ago

Delcath Systems to Participate in the Lytham Partners Fall 2023 Investor Conference

Oct 3, 2023, 8:30 AM EDT - 1 year ago

Delcath Systems to Participate at the Roth MKM 2023 Healthcare Opportunities Conference on October 12, 2023

Sep 11, 2023, 8:00 AM EDT - 1 year ago

A Retrospective Comparative Study of Chemosat and SIRT Presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Meeting